Filter
1726
Filtered Results: 1726
Text search:
drug
registration
Featured
Recommendations
136
New Publications
557
Language
Document type
No document type
1125
Studies & Reports
224
Guidelines
188
Manuals
73
Strategic & Response Plan
68
Fact sheets
17
Training Material
16
Situation Updates
9
Resource Platforms
5
Brochures
1
Countries / Regions
India
168
Kenya
63
Uganda
48
Ethiopia
46
South Africa
42
Tanzania
41
Global
41
Bangladesh
39
Sierra Leone
38
Nigeria
38
Ghana
37
Nepal
37
Malawi
34
Western and Central Europe
34
Liberia
31
Myanmar / Burma
31
Namibia
27
Rwanda
25
Africa
25
Ukraine
24
Zambia
21
Latin America and the Carribbean
19
Eastern Europe
19
Zimbabwe
17
Cambodia
17
Botswana
17
Philippines
15
South–East Asia Region
15
Lesotho
14
Asia
13
Indonesia
11
Syria
9
Congo, Democratic Republic of
8
Mozambique
7
Eswatini/ Swaziland
7
West and Central Africa
6
Russia
6
Pakistan
5
Brazil
5
Colombia
5
East and Southern Africa
5
Senegal
4
South Sudan
4
Benin
4
Sri Lanka
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Albania
4
Tajikistan
4
Georgia
4
Cameroon
3
Haiti
3
Iraq
3
Sudan
3
Argentina
3
Western Pacific Region
3
Bhutan
3
Venezuela
3
Timor Leste/ East Timor
3
Moldova
3
Burkina Faso
2
Jordan
2
Afghanistan
2
Germany
2
Thailand
2
Papua New Guinea
2
North Macedonia
2
Bolivia
2
Libya
2
Angola
2
Chile
2
Paraguay
2
Armenia
2
Laos
2
Iran
2
Uruguay
2
United Kingdom
2
Guinea
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Saudi Arabia
1
Lebanon
1
Gambia
1
China
1
Malaysia
1
Ireland
1
Central African Republic
1
Peru
1
Greece
1
Madagascar
1
Fiji
1
North Korea
1
Italy
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Vietnam
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
877
Clinical Guidelines
133
Public Health
84
Women & Child Health
45
Pharmacy & Technologies
34
Key Resources
28
Capacity Building
20
Toolboxes
TB
193
HIV
167
Mental Health
80
AMR
79
Pharmacy
76
COVID-19
52
NTDs
42
NCDs
34
Caregiver
33
Conflict
27
Refugee
23
Rapid Response
20
Disability
16
Global Health Education
16
Ebola
13
Planetary Health
8
Natural Hazards
7
Specific Hazards
7
Polio
5
Health Financing Toolbox
5
Zika
4
Cholera
3
Social Ethics
2
Health Financing
1
Investigación original / Original research
Rev Panam Salud Publica 35(1), 2014
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug...
Management of Diabetes Mellitus-Tuberculosis
recommended
1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
HIV/AIDS Programme
The current trend in AMR in Uganda and globally is rising and calls for immediate action. The 71st UN General Assembly (UNGA), the 68th World Health Assembly, and organizations including the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the World Organization for ...
The increasing global trend of Antimicrobial resistance (AMR) has gradually emerged as a major public health challenge for the entire world. AMR has spread to almost all countries and regions, including Pakistan owing to the “misuse and overuse” of Antimicrobials, contributing to the increasing ...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
Briefing note | 16 March 2020
Do no harm, equality, transparency, humanity: values should guide the criminal justice sector’s response to coronavirus
At the time of publishing there were more than 164,000* confirmed cases of COVID- 19, the novel form of Coronavirus, affecting 110 countries wit...
10 December 2020
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es...
A Meand to enhancing HIV prevention in key populations. This document has been developed out of the increasing need to set up standards and procedures to prevent and respond to violence against key populations.
